• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Supernus Pharmaceuticals Inc

+ Add to Watchlist

SUPN:US

8.7400 USD 0.0200 0.23%

As of 20:10:00 ET on 12/17/2014.

Company Profile for Supernus Pharmaceuticals Inc (SUPN)

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.

Contact Information

Supernus Pharmaceuticals Inc

1550 East Gude Drive
Rockville, MD 20850
United States
Phone: 1-301-838-2500
Fax: 1-301-424-1364

Key Executives for Supernus Pharmaceuticals Inc (SUPN)

Jack A KhattarPresident/CEO/Secy/FounderStefan K F SchwabeExec VP:R&D/Chief Medical Ofcr
Padmanabh P BhattSenior VP:Intellectual PropertyVictor VaughnSenior VP:Sales
Gregory S PatrickVP/CFOJones W Bryan "Woody"VP:Business Development & Proj

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil